Biotechnology Letters, Vol.36, No.9, 1869-1874, 2014
Structural basis for RKIP binding with its substrate Raf1 kinase
Raf1 kinase inhibitor protein (RKIP) negatively regulates the Raf1/MEK/ERK pathway which is vital for cell growth and differentiation. It is also a biomarker in clinical cancer diagnosis. RKIP binds to the N-terminus of Raf1 kinase but little is known about the structural basis of RKIP binding with Raf1. Here, we demonstrate that the N-terminus of human Raf1 kinase (hRaf1(1-147aa)) binds with human RKIP (hRKIP) at its ligand-binding pocket, loop "127-149", and the C-terminal helix by NMR experiments. D70, D72, E83, Y120, and Y181 were further verified as the key residues participating in the interaction of hRKIP and hRaf1(1-147aa). G143-R146 fragment was also critical for hRKIP binding with hRaf1(1-147aa), for its deletion decreased the binding affinity around 300 times, from 154 to 0.46 mM(-1). Our results provide important structural clues for designing the lead compound that disrupts RKIP-Raf1 interaction.
Keywords:Cancer diagnosis;Fluorescence;hRaf1(1-147aa);hRKIP;Interaction;Nuclear magnetic resonance;Raf1 kinase;Raf1 kinase inhibitor protein